The potential converion to shares is the reason we are not at .03. That being said, they are delivering on partnerships with major companies. Orders are being filled to stock shelves as we speak. There are always pros and cons to every stock. I'm here because ActiPatch works for me.
Debt interest is not deferred it’s forgiven for 2020 and 2021 so no concerns and hopefully they will generate enough revenue to service it thereafter if applicable...
The language in the BIEL PR says "Forego Interest" not 'defer'
Forego - omit or decline to take (something pleasant or valuable); go without.
"The managers of the firm’s two largest lenders, which are both controlled by Whelan family members, Ibex LLC and St. John’s LLC, have agreed to extend foregoing of interest due on their convertible debt notes through the end of 2021. Kelly Whelan, President & CEO of BioElectronics, stated: “It is the goal of both BioElectronics’ management team and the Whelan family to bring the Company to profitability as swiftly as possible, for the benefit of all shareholders. The Whelan family has collectively foregone interest in excess of $750,000 in 2020, and will extend this hiatus on interest collection through at least 2021.”"
"Dr. Staelin noted that “the Board is deeply appreciative of the Whelan family foregoing any interest in 2020 and 2021. This decrease in interest expenses coupled with a steady increase in sales will bring the firm much closer to its goal of posting profits in the near future.”"
News 
Market Data 
Discover 
